2-acylaminomethyl-1,4-benzodiazepine derivatives as CCK-antagoni

Details 2-acylaminomethyl-1,4-benzodiazepine derivatives as CCK-antagoni 2-acylaminomethyl-1,4-benzodiazepine derivatives as CCK-antagoni

1985-11-18

1987-08-04

Robinson, Douglas W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

A61K 3155

Patent

active

046846468

ABSTRACT:
A method of antagonizing the function of cholecystokinins in a disease state in mammals, especially in humans, which comprises administering a pharmaceutically-effective amount of certain 2-acylaminomethyl-1,4-benzodiazepine derivatives or their salts, alone or with a pharmaceutical carrier, with or without an adjuvant.

REFERENCES:
patent: 3738999 (1973-06-01), Krapcho et al.
patent: 3947475 (1976-03-01), DeBaun et al.
patent: 3998809 (1976-12-01), Milkowski et al.
patent: 4096141 (1978-06-01), Milkowski et al.
patent: 4325957 (1982-04-01), Zeugner et al.
patent: 4474777 (1984-10-01), Cassal et al.
patent: 4482548 (1984-11-01), Roemer et al.
patent: 4487771 (1984-12-01), Buglioni
patent: 4533662 (1985-08-01), Zeugner et al.
Chem. Abst. 95:169234(b) (1981)-Zeugner et al.
Chem. Abst. 97:216246(k) (1982)-Zeugner et al.
Chem. Abst. 100:564(v) (1984)-Morley et al.
Chem. Abst. 100:18425k (1984)-Morley et al.

Affiliated with

Also associated with

Rating

2-acylaminomethyl-1,4-benzodiazepine derivatives as CCK-antagoni does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2-acylaminomethyl-1,4-benzodiazepine derivatives as CCK-antagoni, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-acylaminomethyl-1,4-benzodiazepine derivatives as CCK-antagoni will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-883985